A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma
Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2015.1091934
Full Text
Open PDFAbstract
Available in full text
Date
February 8, 2016
Authors
Publisher
Informa UK Limited